nodes	percent_of_prediction	percent_of_DWPC	metapath
Saprisartan—AGTR1—Allograft Rejection—IL22—psoriasis	0.192	0.192	CbGpPWpGaD
Saprisartan—AGTR1—ACE Inhibitor Pathway—REN—psoriasis	0.164	0.164	CbGpPWpGaD
Saprisartan—AGTR1—ACE Inhibitor Pathway—ACE—psoriasis	0.103	0.103	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—HLA-C—psoriasis	0.0365	0.0365	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL13—psoriasis	0.0362	0.0362	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL17A—psoriasis	0.0334	0.0334	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL12B—psoriasis	0.031	0.031	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—HLA-E—psoriasis	0.0303	0.0303	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	0.0294	0.0294	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CCL20—psoriasis	0.0227	0.0227	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL10—psoriasis	0.0227	0.0227	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—HCAR2—psoriasis	0.0224	0.0224	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IL4—psoriasis	0.0221	0.0221	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—HLA-B—psoriasis	0.0216	0.0216	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—HLA-A—psoriasis	0.02	0.02	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—HLA-DRB1—psoriasis	0.0183	0.0183	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—NFKB1—psoriasis	0.016	0.016	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	0.0153	0.0153	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—IFNG—psoriasis	0.0133	0.0133	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—HCAR2—psoriasis	0.0126	0.0126	CbGpPWpGaD
Saprisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—psoriasis	0.0124	0.0124	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—CXCL8—psoriasis	0.0124	0.0124	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CCL20—psoriasis	0.0116	0.0116	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—HCAR2—psoriasis	0.0115	0.0115	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—VEGFA—psoriasis	0.0101	0.0101	CbGpPWpGaD
Saprisartan—AGTR1—Allograft Rejection—TNF—psoriasis	0.00863	0.00863	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—HCAR2—psoriasis	0.00678	0.00678	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CCL20—psoriasis	0.00657	0.00657	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—psoriasis	0.00639	0.00639	CbGpPWpGaD
Saprisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—psoriasis	0.00614	0.00614	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CCL20—psoriasis	0.00596	0.00596	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TAGAP—psoriasis	0.00588	0.00588	CbGpPWpGaD
Saprisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	0.00412	0.00412	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CCL20—psoriasis	0.00352	0.00352	CbGpPWpGaD
Saprisartan—AGTR1—GPCR ligand binding—CXCL8—psoriasis	0.00314	0.00314	CbGpPWpGaD
Saprisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—psoriasis	0.00313	0.00313	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—SOCS1—psoriasis	0.00194	0.00194	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—TYK2—psoriasis	0.00185	0.00185	CbGpPWpGaD
Saprisartan—AGTR1—GPCR downstream signaling—CXCL8—psoriasis	0.00177	0.00177	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—CXCL8—psoriasis	0.00161	0.00161	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—LEP—psoriasis	0.00143	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—APOE—psoriasis	0.00143	0.00143	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NFKBIA—psoriasis	0.00133	0.00133	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TYK2—psoriasis	0.00109	0.00109	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—CXCL8—psoriasis	0.000951	0.000951	CbGpPWpGaD
Saprisartan—AGTR1—Signaling by GPCR—IL6—psoriasis	0.000904	0.000904	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—JUN—psoriasis	0.000884	0.000884	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—NFKB1—psoriasis	0.000851	0.000851	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—VEGFA—psoriasis	0.000773	0.000773	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—STAT3—psoriasis	0.000765	0.000765	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—TP53—psoriasis	0.000584	0.000584	CbGpPWpGaD
Saprisartan—AGTR1—Signaling Pathways—IL6—psoriasis	0.000534	0.000534	CbGpPWpGaD
